Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 9.27 | N/A |
| PEG Ratio (TTM) | -1.87 | N/A |
| P/S Ratio (TTM) | 1.02 | N/A |
| P/B Ratio (TTM) | 2.29 | N/A |
| P/FCF Ratio (TTM) | 9.79 | N/A |
| Price to 5YR AVG Earnings Ratio | 79.87 | N/A |
| Price to 5YR AVG FCF Ratio | 18.13 | N/A |
Profitability (75%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 10.06% | N/A |
| ROE (TTM) | 25.91% | N/A |
| Net Profit Margin (TTM) | 11.04% | N/A |
| ROIC 5YR AVG | 12.58% | N/A |
Growth (15%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -4.18% | -59.46% | -20.65% |
| Revenue | -0.46% | -12.09% | 1.97% |
| Net Income | -4.62% | -59.75% | -20.71% |
| Cash Flow | 23.91% | -14.68% | 5.51% |
Health (79%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.21 | N/A |
| Quick Ratio (TTM) | 1.62 | N/A |
| D/E Ratio (TTM) | 0.74 | N/A |
| Interest Coverage (TTM) | 6.03 | N/A |
| Piotroski F-Score | 9 | N/A |
| Altman Z-Score | 3.44 | N/A |
| LTL to 5YR AVG FCF | 6.58 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.55% | N/A |